Ultragenyx Pharmaceutical
RARE
#4539
Rank
S$3.07 B
Marketcap
S$31.26
Share price
1.54%
Change (1 day)
-34.92%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: S$3.07 Billion

As of June 2026 Ultragenyx Pharmaceutical has a market cap of S$3.07 Billion. This makes Ultragenyx Pharmaceutical the world's 4539th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$3.07 B-27.3%
2025S$4.23 B-22.29%
2024S$5.45 B5.09%
2023S$5.18 B19.1%
2022S$4.35 B-43.81%
2021S$7.74 B-36.04%
2020S$12.11 B263.79%
2019S$3.33 B10.24%
2018S$3.02 B14.35%
2017S$2.64 B-36.46%
2016S$4.15 B-32.61%
2015S$6.16 B233.22%
2014S$1.85 B

End of Day market cap according to different sources

On Jun 13th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

S$3.07 Billion
by Nasdaq info icon info icon
S$3.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
S$1.09 B-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.04 B-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.84 B 89.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.88 B 350.93%๐Ÿ‡บ๐Ÿ‡ธ USA